Mirum Pharmaceuticals, Inc. Basic Shares Outstanding (Weighted Average)
Mirum Pharmaceuticals, Inc. (MIRM) reported Basic Shares Outstanding (Weighted Average) of 63.37 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-05
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 63.37M shares, a 27.44% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 58.85M shares, a 20.38% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 51.52M shares, a 7.02% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 50.64M shares, a 5.98% increase year-over-year.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2025 was 50.20M shares, a 5.63% increase from fiscal 2024.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2024 was 47.52M shares, a 16.23% increase from fiscal 2023.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2023 was 40.89M shares, a 20.82% increase from fiscal 2022.
- Mirum Pharmaceuticals, Inc. weighted average number of shares outstanding, basic for fiscal 2022 was 33.84M shares, a 11.60% increase from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | 63.37M shares 10-Q · filed 2026-08-05 | 61.13M shares 10-Q · filed 2026-08-05 | 57.91M shares derived: average of 3 quarters · filed 2026-08-05 | 56.10M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | 58.85M shares 10-Q · filed 2026-05-06 | 55.18M shares derived: average of 2 quarters · filed 2026-05-06 | 53.67M shares derived: average of 3 quarters · filed 2026-05-06 | 52.68M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | 51.52M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 51.08M shares derived: average of 2 quarters · filed 2026-02-25 | 50.63M shares derived: average of 3 quarters · filed 2026-08-05 | 50.20M shares 10-K · filed 2026-02-25 |
| 2025-09-30 | 50.64M shares 10-Q · filed 2025-11-04 | 50.18M shares derived: average of 2 quarters · filed 2026-08-05 | 49.76M shares 10-Q · filed 2025-11-04 | 49.35M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | 49.73M shares 10-Q · filed 2026-08-05 | 49.31M shares 10-Q · filed 2026-08-05 | 48.92M shares derived: average of 3 quarters · filed 2026-08-05 | 48.63M shares derived: average of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | 48.89M shares 10-Q · filed 2026-05-06 | 48.51M shares derived: average of 2 quarters · filed 2026-05-06 | 48.27M shares derived: average of 3 quarters · filed 2026-05-06 | 48.01M shares derived: average of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | 48.14M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 47.96M shares derived: average of 2 quarters · filed 2026-02-25 | 47.72M shares derived: average of 3 quarters · filed 2026-02-25 | 47.52M shares 10-K · filed 2026-02-25 |
| 2024-09-30 | 47.78M shares 10-Q · filed 2025-11-04 | 47.51M shares derived: average of 2 quarters · filed 2025-11-04 | 47.32M shares 10-Q · filed 2025-11-04 | 47.14M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | 47.24M shares 10-Q · filed 2025-08-06 | 47.08M shares 10-Q · filed 2025-08-06 | 46.93M shares derived: average of 3 quarters · filed 2026-02-25 | 45.47M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | 46.93M shares 10-Q · filed 2025-05-07 | 46.77M shares derived: average of 2 quarters · filed 2026-02-25 | 44.88M shares derived: average of 3 quarters · filed 2026-02-25 | 43.19M shares derived: average of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | 46.62M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 43.86M shares derived: average of 2 quarters · filed 2026-02-25 | 41.94M shares derived: average of 3 quarters · filed 2026-02-25 | 40.89M shares 10-K · filed 2026-02-25 |
| 2023-09-30 | 41.10M shares 10-Q · filed 2024-11-12 | 39.60M shares derived: average of 2 quarters · filed 2024-11-12 | 38.97M shares 10-Q · filed 2024-11-12 | 38.45M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | 38.11M shares 10-Q · filed 2024-08-07 | 37.89M shares 10-Q · filed 2024-08-07 | 37.57M shares derived: average of 3 quarters · filed 2025-02-26 | 36.91M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | 37.68M shares 10-Q · filed 2024-05-08 | 37.30M shares derived: average of 2 quarters · filed 2025-02-26 | 36.51M shares derived: average of 3 quarters · filed 2025-02-26 | 35.42M shares derived: average of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | 36.93M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | 35.93M shares derived: average of 2 quarters · filed 2025-02-26 | 34.67M shares derived: average of 3 quarters · filed 2025-02-26 | 33.84M shares 10-K · filed 2025-02-26 |
| 2022-09-30 | 34.93M shares 10-Q · filed 2023-11-02 | 33.55M shares derived: average of 2 quarters · filed 2023-11-02 | 32.81M shares 10-Q · filed 2023-11-02 | 32.23M shares derived: average of 4 quarters · filed 2024-03-15 |
| 2022-06-30 | 32.16M shares 10-Q · filed 2023-08-07 | 31.73M shares 10-Q · filed 2023-08-07 | 31.33M shares derived: average of 3 quarters · filed 2024-03-15 | 31.09M shares derived: average of 4 quarters · filed 2024-03-15 |
| 2022-03-31 | 31.30M shares 10-Q · filed 2023-05-04 | 30.92M shares derived: average of 2 quarters · filed 2024-03-15 | 30.73M shares derived: average of 3 quarters · filed 2024-03-15 | 30.62M shares derived: average of 4 quarters · filed 2024-03-15 |
| 2021-12-31 | 30.54M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15 | 30.45M shares derived: average of 2 quarters · filed 2024-03-15 | 30.39M shares derived: average of 3 quarters · filed 2024-03-15 | 30.32M shares 10-K · filed 2024-03-15 |
| 2021-09-30 | 30.37M shares 10-Q · filed 2022-11-09 | 30.32M shares derived: average of 2 quarters · filed 2022-11-09 | 30.25M shares 10-Q · filed 2022-11-09 | |
| 2021-06-30 | 30.27M shares 10-Q · filed 2022-08-04 | 30.19M shares 10-Q · filed 2022-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |